Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer
Shiga, T.; Kawauchi, A.; Kamiya, K.; Ishii, J.; Uzawa, R.; Gomi, K.
Rinsho Byori. Japanese Journal of Clinical Pathology 34(11): 1339-1345
1986
ISSN/ISBN: 0047-1860 PMID: 3469447 Document Number: 281196
Document emailed within 1 workday
Related Documents
Messina, G.; Lissoni, P.; Brivio, F.; Rovelli, F.; Fumagalli, L.; Bartolacelli, E.; Mazza, U.; Colombo, E.; Bertoglio, A. 2008: A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour In Vivo 22(6): 845-848Partanen, S.; Pekonen, F. 1989: Histochemically demonstrable phosphotyrosyl-protein phosphatase in normal human breast, in benign breast diseases and in breast cancer Anticancer Research 9(3): 667-671
Albeshan, S.M.; Hossain, S.Z.; Mackey, M.G.; Brennan, P.C. 2020: Can Breast Self-examination and Clinical Breast Examination Along with Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations with Advanced Stages at Diagnosis? Clinical Breast Cancer 20(3): 194-200
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Stierli, P.; Spichtig, S.; Aeberhard, P. 1992: Breast saving therapy of breast cancer: sensitivity of mammography in relation to primary tumor size Helvetica Chirurgica Acta 59(1): 247-252
Yokdang, N.; Buxton, N.D.; Buxton, I.L.O. 2009: Measurement of human breast tumor cell-secreted shNDPK-B in a murine breast cancer model suggests its role in metastatic progression Proceedings of the Western Pharmacology Society 52: 88-91
Steinberg, J.L.; Trudeau, M.E.; Ryder, D.E.; Fishell, E.; Chapman, J.A.; McCready, D.R.; Fish, E.B.; Hiraki, G.Y.; Ross, T.M.; Lickley, L.A. 1996: Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 39(4): 302-311
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
McPherson, K.; Steel, C.M.; Dixon, J.M. 1994: ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics Bmj 309(6960): 1003-1006
Tokuda, Y. 2014: The Japanese Breast Cancer Society Breast Cancer Registry in the National Clinical Database: current status and future perspectives Nihon Geka Gakkai zasshi 115(1): 17-21
Gao, D.-l.; Hu, Y.-w.; Wang, W.-w.; Chen, F.-l.; Pan, L.-d.; Yuan, Y.; Yu, L.-d.; Qian, F. 2006: Evaluation on the effect of intervention regarding breast self-examination for decreasing breast cancer mortality Zhonghua Liu Xing Bing Xue Za Zhi 27(11): 985-990
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Pediconi, F.; Venditti, F.; Padula, S.; Roselli, A.; Moriconi, E.; Giacomelli, L.; Catalano, C.; Passariello, R. 2005: CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer La Radiologia Medica 110(1-2): 61-68
Falkiewicz, B.; Schlotter, C.M.; Bosse, U.; Bielawski, K.; Vogt, U. 2000: c-myc oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer Acta Biochimica Polonica 47(1): 149-156
Pina Insausti, L.; Pons Renedo, M.J. 2008: Evaluation of the contralateral breast with magnetic resonance in patients with newly diagnosed unilateral breast cancer Revista de Medicina de la Universidad de Navarra 52(1): 37-39
Penault-Llorca, F.; Jacquemier, J.; Le Doussal, V.; Voigt, J.J. 1999: Quality challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer. Group for Evaluation of Prognostic Factors in Immunohistochemistry in Breast Cancer (GEFPICS) Annales de Pathologie 19(4): 280-282
Nabholtz, J.M.; Lindsay, M.A.; Hugh, J.; Mackey, J.; Smylie, M.; Au, H.J.; Tonkin, K.; Allen, M. 1999: The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group Seminars in Oncology 26(3 Suppl. 8): 4-8
Wang, S-Sheng.; Zhang, Y-Na.; Sun, Q.; Wang, Z-Jie.; Wang, J.; Sha-Ren, G-Wa. 2010: Reduction of missing report rate of breast cancer in clinical breast examination Zhonghua Yi Xue Za Zhi 90(48): 3415-3417
Lumachi, F.; Ermani, M.; Basso, S.M.; Lonardi, S.; Tosoni, A.; Brandes, A.A. 2003: Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examination Anticancer Research 23(4): 3565-3568
Yamazaki, Z.; Kuno, K.; Fukami, A.; Hirose, M.; Oashi, Y. 1971: Clinical studies of breast thermography and its significance as an auxiliary diagnostic test of breast cancer Gan no Rinsho. Japan Journal of Cancer Clinics 17(9): 663-669